Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1969 Aug;45(526):571–573. doi: 10.1136/pgmj.45.526.571

Is there a place for proteinase inhibition? A review of the literature

G D Lister
PMCID: PMC2466889  PMID: 4898866

Abstract

The evidence demonstrating excessive proteinase activity in states of shock is reviewed. The capacity of extrinsic inhibitors to control such activity is indicated and the literature showing the value of inhibitors in treating shock is summarized. Three principles to be observed in the use of exogenous inhibitors are proposed.

Full text

PDF
571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amris C. J. Inhibition of fibrinolytic and thromboplastic activity by Trasylol. Scand J Haematol. 1966;3(1):19–32. doi: 10.1111/j.1600-0609.1966.tb00622.x. [DOI] [PubMed] [Google Scholar]
  2. Attar S. M., Tingey H. B., McLaughlin J. S., Cowley R. A. Bradykinin in human shock. Surg Forum. 1967;18:46–47. [PubMed] [Google Scholar]
  3. BECK E., SCHMUTZLER R., DUCKERT F. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR. Thromb Diath Haemorrh. 1963 Nov 1;10:106–119. [PubMed] [Google Scholar]
  4. BERALDO W. T. Formation of bradykinin in anaphylactic and peptone shock. Am J Physiol. 1950 Nov;163(2):283–289. doi: 10.1152/ajplegacy.1950.163.2.283. [DOI] [PubMed] [Google Scholar]
  5. Back N. Fibrinolysin system and vasoactive kinins. Fed Proc. 1966 Jan-Feb;25(1):77–83. [PubMed] [Google Scholar]
  6. Brockman S. K., Thomas C. S., Jr, Vasko J. S. The effect of Escherichia coli endotoxin on the circulation. Surg Gynecol Obstet. 1967 Oct;125(4):763–774. [PubMed] [Google Scholar]
  7. Corrado A. P., Reis M. L., Carvalho I. F., Diniz C. R. Bradykininogen and bradykinin in the cardiovascular shock produced by proteolytic enzymes. Biochem Pharmacol. 1966 Jul;15(7):959–970. doi: 10.1016/0006-2952(66)90173-0. [DOI] [PubMed] [Google Scholar]
  8. DINIZ C. R., CARVALHO I. F., RYAN J., ROCHA E SILVA M. A micromethod for the determination of bradykininogen in blood plasma. Nature. 1961 Dec 23;192:1194–1195. doi: 10.1038/1921194a0. [DOI] [PubMed] [Google Scholar]
  9. Dubber A. H., McNicol G. P., Uttley D., Douglas A. S. In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor. Br J Haematol. 1968 Jan;14(1):31–49. doi: 10.1111/j.1365-2141.1968.tb01470.x. [DOI] [PubMed] [Google Scholar]
  10. EISEN V. FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES. Br Med Bull. 1964 Sep;20:205–209. doi: 10.1093/oxfordjournals.bmb.a070332. [DOI] [PubMed] [Google Scholar]
  11. GILBERT R. P. Mechanisms of the hemodynamic effects of endotoxin. Physiol Rev. 1960 Apr;40:245–279. doi: 10.1152/physrev.1960.40.2.245. [DOI] [PubMed] [Google Scholar]
  12. KOBOLD E. E., LUCAS R., THAL A. P. CHEMICAL MEDIATORS IN CLINICAL SEPTIC SHOCK. Surg Forum. 1963;14:16–19. [PubMed] [Google Scholar]
  13. KOBOLD E. E., THAL A. P. QUANTITATION AND IDENTIFICATION OF VASOACTIVE SUBSTANCES LIBERATED DURING VARIOUS TYPES OF EXPERIMENTAL AND CLINICAL INTESTINAL ISCHEMIA. Surg Gynecol Obstet. 1963 Sep;117:315–322. [PubMed] [Google Scholar]
  14. MCCUTCHEON A. D. EXPERIMENTAL PANCREATITIS: USE OF A NEW ANTIPROTEOLYTIC SUBSTANCE, TRASYLOL. Ann Surg. 1963 Aug;158:233–239. doi: 10.1097/00000658-196308000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MCNICOL G. P., DOUGLAS A. S. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS. Br Med Bull. 1964 Sep;20:233–239. doi: 10.1093/oxfordjournals.bmb.a070338. [DOI] [PubMed] [Google Scholar]
  16. McKay D. G., Margaretten W., Csavossy I. An electron microscope study of endotoxin shock in rhesus monkeys. Surg Gynecol Obstet. 1967 Oct;125(4):825–832. [PubMed] [Google Scholar]
  17. NAEYE R. L. Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocapproic acid. Blood. 1962 Jun;19:694–701. [PubMed] [Google Scholar]
  18. Nordström S., Olsson P., Blombäck M. Thromboplastin-induced hypercoagulability and its prevention. Nature. 1965 May 8;206(984):632–633. doi: 10.1038/206632b0. [DOI] [PubMed] [Google Scholar]
  20. Rothschild A. M., Castania A. Endotoxin shock in dogs pretreated with cellulose sulphate, an agent causing partial plasma kininogen depletion. J Pharm Pharmacol. 1968 Jan;20(1):77–78. doi: 10.1111/j.2042-7158.1968.tb09628.x. [DOI] [PubMed] [Google Scholar]
  21. Rutherford R. B., West R. L., Hardaway R. M., 3rd Coagulation changes during experimental hemorrhagic shock. Clotting activity, contribution of splanchnic circulation and acidosis as controlled by THAM. Ann Surg. 1966 Aug;164(2):203–214. doi: 10.1097/00000658-196608000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SHARP A. A. PATHOLOGICAL FIBRINOLYSIS. Br Med Bull. 1964 Sep;20:240–246. doi: 10.1093/oxfordjournals.bmb.a070339. [DOI] [PubMed] [Google Scholar]
  23. SHERRY S., FLETCHER A. P., ALKJAERSIG N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev. 1959 Apr;39(2):343–382. doi: 10.1152/physrev.1959.39.2.343. [DOI] [PubMed] [Google Scholar]
  24. SMITH R. B., 3rd, ORAHOOD R. C., WANGENSTEEN S. L., BERAKHA G. J., ZAMELIS A. EFFECT OF A TRYPSIN-INHIBITOR ON EXPERIMENTALLY INDUCED PANCREATITIS IN THE DOG. Surgery. 1963 Dec;54:922–927. [PubMed] [Google Scholar]
  25. STEICHELE D. F., HERSCHLEIN H. J. [On the antifibrinolytic effect of trypsin--kallikrein inactivator]. Med Welt. 1961 Oct 21;42:2170–2172. [PubMed] [Google Scholar]
  26. THAL A. P., KOBOLD E. E., HOLLENBERG M. J. The release of vasoactive substances in acute pancreatitis. Am J Surg. 1963 Jun;105:708–713. doi: 10.1016/0002-9610(63)90482-3. [DOI] [PubMed] [Google Scholar]
  27. TICE D. A., REED G. E., CLAUSS R. H., WORTH M. H. HEMORRHAGE DUE TO FIBRINOLYSIS OCCURRING WITH OPEN-HEART OPERATIONS. J Thorac Cardiovasc Surg. 1963 Nov;46:673–679. [PubMed] [Google Scholar]
  28. TICE D. A., WORTH M. H., Jr, CLAUSS R. H., REED G. H. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS. Surg Gynecol Obstet. 1964 Jul;119:71–74. [PubMed] [Google Scholar]
  29. WEBSTER M. E., CLARK W. R. Significance of the callicreincallidinogen-callidin system in shock. Am J Physiol. 1959 Aug;197:406–412. doi: 10.1152/ajplegacy.1959.197.2.406. [DOI] [PubMed] [Google Scholar]
  30. WEIL M. H., SUDRANN R. B., SHUBIN H. Treatment of endotoxic shock--the dilemma of vasopressor and vasodilator therapy. Calif Med. 1962 Feb;96:86–88. [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES